YOLFTbeta
Trivarx Ltd

Trivarx Ltd

TRI · AU · Healthcare / Health Information Services

0.009AUD-0.00 (-10.00%)

Price History

Full chart

Market Stats

Previous Close0.01
Open0.01
Day Range0.009 – 0.01
52-Week Range0.009 – 0.035
Volume763.57K
Market Cap11.54M
P/E (TTM)0.00
Forward P/E5.58
EPS-0.96
Dividend Yield0.00%
Beta1.04
50-Day Avg0.0136
200-Day Avg0.0195

About

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Kai Sun
  • Employees0
  • HeadquartersSuite 1.01, Hawthorn East, VIC, Australia, 3123, Australia
  • Websitehttps://trivarx.com

Leadership

  • Mr. Kai SunChief Operating Officer
  • Dr. Anthony James KeatingExecutive Director

Financials

Income Statement

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue140.72K155.38K57.59K36.76K113.05K17.16K8.36K91.00K-1.46K294.04K52.40K19.23K0261.93K18.50K23.10K204.88K364.63K133.50K101.66K40.04K22.07K893.31K1.13M-
Growth (%)-+10.42%-62.93%-36.18%+207.59%-84.82%-51.30%+989.04%--+20095.19%-82.18%-63.30%-100.00%--92.94%+24.86%+786.92%+77.97%-63.39%-23.85%-60.61%-44.87%+3946.89%+26.38%-
Cost of Revenue--721.00K--540.00K499.00K--834237.90K442.66K198.87K000075.67K226.09K204.69K170.70K1.07K15893.13K52.47K6.47M
Gross Profit140.72K155.38K57.59K36.76K113.05K17.16K8.36K--62256.14K-390.26K-179.63K0255.12K18.50K23.10K129.21K138.54K-71.19K-69.04K38.97K21.92K-93.13K-52.47K-6.47M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%--42.72%19.09%-744.82%-934.14%-97.40%100.00%100.00%63.07%37.99%-53.32%-67.92%97.33%99.28%-10.43%-4.65%-
Operating Expense2.10M4.17M3.86M2.28M1.81M1.04M971.00K--3.15M3.88M2.85M732.87K791.28K3.97M7.32M12.67M18.82M6.71M3.76M2.57M3.68M2.70M2.22M1.99M1.95M
Operating Income-1.96M-4.01M-3.80M-2.24M-1.70M-1.02M-962.64K-3.24M-2.29M-3.15M-3.82M-3.24M-912.50K-791.28K-3.72M-7.30M-12.65M-18.69M-6.57M-3.84M-2.63M-3.64M-2.68M-2.31M-2.04M-8.42M
Operating Margin-1389.76%-2583.54%-6599.11%-6104.64%-1504.52%-5946.97%-11520.40%-3562.51%--216123.63%-1300.48%-6182.64%-4745.20%--1419.07%-39445.66%-54770.03%-9121.50%-1802.69%-2873.20%-2591.57%-9086.82%-12129.91%-259.09%-180.57%-
EBITDA-1.51M-3.34M-2.95M-1.90M-3.47M-970.34K-1.46M-2.45M-893.69K-3.37M-3.60M-3.45M-899.62K-321.11K-2.94M-4.25M-7.79M-14.96M-6.42M-3.69M-1.28M-12.33M-2.57M-1.13M-1.89M-1.95M
EBITDA Margin-1075.80%-2151.76%-5115.64%-5168.41%-3069.71%-5654.96%-17430.03%-2689.25%--231277.06%-1225.80%-6585.71%-4678.20%--1121.90%-22968.06%-33730.11%-7303.26%-1761.86%-2761.69%-1260.91%-30787.80%-11621.87%-126.55%-167.25%-
Net Income187.26K757.06K79.77K--1.83M-777.88K-1.43M-4.66M-3.04M-3.30M-3.22M-3.33M-1.10M-428.33K-7.92M-5.82M-9.79M-16.30M-6.59M-4.70M-1.49M-12.72M-3.12M-1.24M-943.23K-8.76M
Net Income Margin133.08%487.25%138.52%--1617.34%-4533.35%-17111.58%-5117.77%--226748.21%-1095.12%-6349.51%-5703.14%--3024.36%-31483.09%-42359.62%-7956.14%-1806.51%-3521.24%-1462.38%-31759.35%-14132.93%-138.48%-83.55%-
R&D-452.01K454.38K527.86K195.07K99.60K191.64K1.17M711.98K717.95K720.54K388.19K2.57K15.09K210.66K1.85M4.32M3.26M394.91K359.95K430.77K802.90K307.15K14.27K26.39K10.34K
R&D as % of Total Revenue-290.91%789.00%1436.16%172.55%580.45%2293.41%1285.86%-49309.48%245.05%740.87%13.38%-80.43%10017.66%18705.34%1588.87%108.30%269.63%423.75%2005.33%1391.45%1.60%2.34%-
Interest Expense000000000000000008.14K13.93K36.69K6.29K5.32K13.26K13.45K33.63K12.49K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.00%0.00%0.00%0.00%-0.00%0.00%0.00%3.97%3.82%27.48%6.19%13.28%60.07%1.51%2.98%-

Balance Sheet

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets7.00M6.96M5.44M5.13M4.68M2.44M2.06M6.17M2.72M1.41M3.28M5.48M5.42M5.04M15.18M17.92M19.25M19.06M13.30M14.01M17.38M8.49M7.89M10.81M13.48M16.53M
Total Liabilities951.79K912.54K287.58K276.96K239.59K183.98K179.82K497.07K262.24K311.02K2.10M3.03M2.88M2.33M6.07M9.43M5.94M5.08M4.70M1.40M963.68K1.38M1.76M1.18M831.22K565.64K
Total Equity6.23M6.01M5.15M4.86M4.44M2.26M1.88M5.68M2.46M1.10M1.18M2.44M2.54M2.71M9.11M8.49M13.31M13.99M8.60M12.61M16.42M7.11M6.30M9.88M12.65M15.97M
Cash1.65M927.23K469.15K1.12M725.35K1.81M1.95M3.90M2.14M738.67K1.72M85.32K180.94K96.25K944.30K1.04M5.01M6.12M1.33M812.50K2.31M1.03M214.11K848.10K1.25M2.44M
Total Debt61.58K211.78K33.90K22.91K23.12K------2.25M2.40M1.90M3.69M3.69M132.50K120.00K2.75M76.91K24.81K66.42K103.70K15.90K169.03K128.14K
Net Debt-1.58M-715.45K-435.25K-1.10M-702.24K-1.81M-1.95M-3.90M-2.14M-738.67K-1.72M2.16M2.22M1.80M2.75M2.65M-4.88M-6.00M1.42M-735.60K-2.29M-966.15K-110.41K-832.20K-1.08M-2.32M

Cash Flow

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-1.57M-3.89M--1.10M-997.01K-818.20K-992.15K-1.93M-2.05M-2.61M-3.67M-1.51M-1.18M-611.26K-1.52M-2.70M-5.42M-12.27M-6.85M-3.59M-1.70M-12.28M-932.08K-1.48M-189.74K-1.51M
Investing Cash Flow--79.00K--67.00K83.00K-294.00K----1.35M-1.09M-36.08K34.24K-399.62K-1.06M-1.50M-1.83M-3.11M-2.26M-2.85M-2.09M-1.17M
Financing Cash Flow2.69M3.77M1.81M1.87M1.25M1.84M1.05M4.51M-1.27M4.69M2.44M1.29M-827.08K3.45M2.83M9.36M13.78M3.12M4.55M4.92M3.33M2.47M4.32M2.68M3.87M
Capital Expenditure121.56K348.32K12.93K11.41K03.57K2.14K808.45K7.52K31.32K4.75K3.63K0343.75K1.09M61.38K001.14M1.54M1.83M3.11M2.26M2.85M2.09M1.51M
Free Cash Flow-1.69M-4.23M-2.36M-1.11M-997.01K-821.77K-994.29K-2.74M-2.06M-2.65M-3.67M-1.52M-1.18M-955.01K-2.60M-2.76M-5.42M-12.27M-7.99M-5.13M-3.53M-15.39M-3.19M-3.70M-189.74K-
Dividends Paid---------------00---------
FCF to OCF107.75%108.96%-101.03%100.00%100.44%100.22%141.91%100.37%101.20%100.13%100.24%100.00%156.24%171.76%102.27%100.00%100.00%116.63%142.95%207.78%125.33%342.33%250.57%100.00%-
Dividend Paid to FCF---------------0.00%0.00%---------

Earnings

Report DateFeb 26, 2016Sep 30, 2016Oct 1, 2016Feb 28, 2017Oct 24, 2017Feb 27, 2018Aug 29, 2018Feb 27, 2019Aug 30, 2019Feb 28, 2020Aug 28, 2020Feb 24, 2021Aug 31, 2021Feb 25, 2022Sep 30, 2022Feb 24, 2023Feb 28, 2025Sep 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.00
EPS Actual-0.01-0.05-0.05-0.02-0.05-0.03-0.09-0.02-0.010.000.000.000.000.00-0.010.000.000.00
Surprise------------------
Timing---------------After-hours--

Key Statistics & Ratios

Market Cap11.54M
Enterprise Value10.38M
Trailing P/E0.00
Forward P/E5.58
Price / Sales792.05
Price / Book0.79
EPS-0.96
Book Value0.02
Revenue (TTM)14.57K
Gross Profit (TTM)14.57K
EBITDA-3.35M
Profit Margin0.00%
Operating Margin315936.13%
Return on Equity-61.23%
Return on Assets-35.07%
Shares Outstanding1.15B
Shares Float901.38M
Beta1.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 23, 20231:20
  • Mar 10, 20151:100